- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | EPIMINDER LIMITED: FY26 Investor Presentation | - | ASX | ||
| Do | EPIMINDER LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 16.07. | EPIMINDER LIMITED: Trading Update | - | ASX | ||
| 05.06. | EPIMINDER LIMITED: Change of Director's Interest Notice PB | - | ASX | ||
| 01.06. | EPIMINDER LIMITED: DETECT Study reaches 25th enrolment as momentum builds | - | ASX | ||
| 29.05. | EPIMINDER LIMITED: Change of Auditor | - | ASX | ||
| 18.05. | EPIMINDER LIMITED: Change of Director's Interest Notice DO | - | ASX | ||
| EPIMINDER Aktie jetzt für 0€ handeln | |||||
| 18.05. | EPIMINDER LIMITED: Change of Director's Interest Notice PO | - | ASX | ||
| 15.05. | EPIMINDER LIMITED: Change of Director's Interest Notice RK | - | ASX | ||
| 15.05. | EPIMINDER LIMITED: Change of Director's Interest Notice JS | - | ASX | ||
| 30.04. | EPIMINDER LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 16.04. | EPIMINDER LIMITED: Change of Auditor | - | ASX | ||
| 17.03. | EPIMINDER LIMITED: Change of Director's Interest Notice PB | 1 | ASX | ||
| 03.03. | EPIMINDER LIMITED: Change of Director's Interest Notice RK | 1 | ASX | ||
| 24.02. | EPIMINDER LIMITED: 1H FY26 Results Presentation | - | ASX | ||
| 24.02. | EPIMINDER LIMITED: 1H FY26 Results Announcement | - | ASX | ||
| 24.02. | EPIMINDER LIMITED: 1HFY26 Appendix 4D and Financial Report | - | ASX | ||
| 09.02. | EPIMINDER LIMITED: Notification of Results/Reporting Date | 2 | ASX | ||
| 11.12.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 11.12.2025 | 837 | Xetra Newsboard | The following instruments on XETRA do have their first trading 11.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.12.2025
Aktien
1 AU0000410128 Ariana Resources PLC
2... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 59,71 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 14,855 | +0,03 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,670 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,540 | +4,56 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BILLIONTOONE | 138,54 | -0,04 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 65,07 | -0,06 % | NSE - GeneDx Holdings Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| HEARTFLOW | 25,230 | 0,00 % | Baird startet Coverage für HeartFlow mit "Outperform" | ||
| MANGOCEUTICALS | 0,558 | +0,14 % | Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor | Mississauga, Ontario--(Newsfile Corp. - July 30, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing... ► Artikel lesen | |
| BETA BIONICS | 12,820 | -0,08 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROGYNY | 31,130 | 0,00 % | Barclays downgrades Progyny stock rating on utilization concerns | ||
| SANARA MEDTECH | 33,900 | +0,12 % | MiMedx Group, Inc.: MIMEDX to Acquire Sanara MedTech | Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX's Strategic Priority to Expand Surgical Footprint, Nearly Doubling... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 10,475 | -0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PACS GROUP | 46,120 | +0,17 % | Hohes Handelsaufkommen bei Optionen der Pacs Group | ||
| PROCEPT BIOROBOTICS | 18,630 | +0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 44,640 | +0,27 % | Aktien Frankfurt: 'Old economy' schiebt Dax weiter in Richtung Rekordhoch | FRANKFURT (dpa-AFX) - Die weiter nachgebenden Energiepreise haben am deutschen Aktienmarkt am Dienstag für weitere Entspannung gesorgt. Der Dax knüpfte gegen Mittag mit plus 0,61 Prozent auf 25.517... ► Artikel lesen |
Das Unternehmen EPIMINDER LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +18,24 % bei einem Aktienkurs von 0,188 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPIMINDER LIMITED finden Sie auf Wallstreet Online.